Success Story: NIW Approved Without an RFE! Our Firm Helped an Indian Postdoctoral Researcher Secure Success in 2 Months
Client’s Testimonial:
"I thank NAILG for preparing my successful NIW application, translating and organizing my academic CV into a petition that carefully explained how I met the criteria.”
On February 2nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Researcher in the Field of Cell and Molecular Biology (Approval Notice).
General Field: Cell and Molecular Biology
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: February 2nd, 2026
Processing Time: 1 month, 29 days (Premium Processing Upgrade Requested)
Case Summary:
North America Immigration Law Group (NAILG) is pleased to share the successful I-140 EB-2 National Interest Waiver (NIW) approval for our client, a researcher who holds a Ph.D. in molecular, cellular, and developmental biology. The client approached our firm seeking support in securing permanent residency through an NIW petition centered on the national importance of enabling new therapeutic strategies for cancer and other complex diseases. After a thorough review of the client’s background and research direction, our team prepared a clear, evidence-driven filing that resulted in approval.
Research Endeavor and National Importance The client’s proposed endeavor is to continue designing and utilizing methods for quantifying cell signaling activity to identify key growth regulators, using both cell culture and genetically modified animal models. In practical terms, this work helps translate signaling behavior into actionable biological insights, supporting the discovery of new drug targets and enabling the development of more effective therapies for cancer and other complex diseases.
The client currently works in a research fellow role at a U.S.-based pediatric hospital and research environment, where the day-to-day focus supports continued investigation into disease mechanisms and therapeutic target discovery. The petition framed this ongoing role as a credible pathway for sustained contributions in the United States, rather than a speculative future plan.
Accomplishments and Evidence In NIW cases, metrics matter most when they reflect external validation and a durable research direction, not merely routine publication activity. We organized the record to show that the client’s work has already generated independent reliance and recognizable influence, which are the types of signals adjudicators look for when evaluating whether a researcher is well-positioned to advance an endeavor of national importance.
Key objective indicators included:
- Scholarly output: 6 peer-reviewed journal articles (including 4 first-authored or co-first-authored)
- Citation reliance: 266 citations to the client’s published body of work
- Citation quality signals: multiple publications reaching top-cited percentile ranges for their publication year within the relevant category, supporting that the work is being used at an above-typical rate compared to field and time benchmarks
- Research support: funding tied to the National Institutes of Health (NIH), an objective indicator that the work has been competitively assessed and aligns with high-priority biomedical goals
NIW Approval and Outlook USCIS approved the NIW petition without an RFE, acknowledging that the client’s cell and molecular biology research holds clear national-scale value and demonstrates strong positioning through a focused research agenda, peer-validated publications, and documented independent reliance. NAILG is honored to have supported the client in achieving this NIW approval and looks forward to the client’s continued contributions to drug target discovery and therapy development in the United States.